Pharmaceuticals

Q/C Tech

Q/C Tech released FY2025 9 Months earnings on November 19 (EST), actual revenue USD 0, actual EPS USD -56.395

Q/C Tech released FY2025 Q3 earnings on November 19 (EST), actual revenue USD 0, actual EPS USD -2.5033

Q/C Tech released FY2024 Q3 earnings on August 19 (EST), actual revenue USD 0, actual EPS USD -107.618

Q/C Tech released FY2024 Semi-Annual Earnings on August 19 Post-Market (EST), Actual Revenue USD 0, Actual EPS USD -957.9434

Q/C Tech released FY2025 Semi-Annual Earnings on August 19, 2025 (EST) with actual revenue of USD 0 and EPS of USD -44.6403

Q/C Tech released FY2024 9 Months earnings on August 19 (EST), actual revenue USD 0, actual EPS USD -1.079K

Q/C Tech released FY2025 Q2 earnings on August 19 (EST) with actual revenue of USD 0 and EPS of USD -17.6608

Q/C Tech released FY2024 Q2 earnings on August 19 (EST), actual revenue USD 0, actual EPS USD -454.4969

Q/C Tech released FY2025 Q1 earnings on May 15, 2025 (EST) with actual revenue of USD 0 and actual EPS of USD -36.2307

Q/C Tech released FY2024 Q1 earnings on May 15 (EST), actual revenue USD 0, actual EPS USD -513.8437

Q/C Tech released FY2023 earnings on April 11, 2025 (EST) with actual revenue of USD 0 and EPS of USD -532.782

Q/C Tech released FY2023 Q4 earnings on April 11 (EST), actual revenue USD 0, actual EPS USD -271.9337

Q/C Tech released FY2024 Annual Earnings on April 11, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.115 K

Q/C Tech released FY2024 Q4 earnings on April 11, 2025 (EST) with actual revenue of USD 0 and EPS of USD -109.074

Q/C Tech released FY2023 Q3 earnings on November 14 (EST), actual revenue USD 0, actual EPS USD 37

Processa Pharmaceuticals

Agape ATP

cbdMD

VYNE Therapeutics

Mega Fortune

Inspirato

Medline Inc.

Globavend

DBV Tech

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap